Cases & Deals

Odyssey Thera raises capital in Series A-2 round

Clients Odyssey Thera, Inc.

Jones Day represented Odyssey Thera, Inc., a privately held biotechnology company, in connection with its issuance of Series A-2 Preferred Stock in private placement to Merck & Co., Inc. and previous investors HBM Partners, Burrill & Company, and Lonza.